Vendor Intelligence Report: Mix Peptides

Published 13 Jun 2026. 22-page investigative report on who is behind Mix Peptides: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 4 pages are free to read on this page.

Across 34 Finnrick lab tests, Mix Peptides shows a 71% overall pass rate, with Retatrutide less adverse than Tirzepatide but both affected by lot-to-lot inconsistency. The full report traces the…